$ECL Cashflow Statement | Understand Stock

$ECL

$292.41 +$1.14 (0.39%) Close

$ECL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES
Net income including noncontrolling interest
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation
Amortization
Deferred income taxes
Share-based compensation expense
Pension and postretirement plan contributions
Pension and postretirement plan expense (income), net
Restructuring charges, net of cash paid
Debt refinancing
Sale of global surgical solutions business
Other, net
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable
Inventories
Other assets
Accounts payable
Other liabilities

Cash provided by operating activities
INVESTING ACTIVITIES
Capital expenditures
Property and other assets sold
Acquisitions and investments in affiliates, net of cash acquired
Divestiture of businesses, net of cash divested
Other, net
Cash used for investing activities
FINANCING ACTIVITIES
Net issuances (repayments) of commercial paper and notes payable
Long-term debt borrowings
Long-term debt repayments
Reacquired shares
Dividends paid
Exercise of employee stock options
Debt refinancing
Hedge settlements
Other, net
Cash used for financing activities

Effect of exchange rate changes on cash and cash equivalents
(Decrease) Increase in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
SUPPLEMENTAL CASH FLOW INFORMATION
Income taxes paid
Net interest paid

Comments